4//SEC Filing
Brown Bob D 4
Accession 0001399529-21-000152
CIK 0001399529other
Filed
Sep 20, 8:00 PM ET
Accepted
Sep 21, 5:37 PM ET
Size
6.0 KB
Accession
0001399529-21-000152
Insider Transaction Report
Form 4
Brown Bob
Chief Scientific Officer, SVP
Transactions
- Sale
Common Stock
2021-09-17$21.06/sh−21,250$447,517→ 267 total
Footnotes (3)
- [F1]The Reporting Person sold an aggregate of 21,250 shares of Common Stock on September 17, 2021 (the "Shares Sold") as reported in this Form 4. The Shares Sold represent 2.40% of 886,953 shares of Common Stock, which is the number of shares of Common Stock owned by the Reporting Person prior to the Shares Sold transaction reported in this Form 4, as well as shares issuable upon exercise or settlement of vested and unvested options and restricted stock units held by the Reporting Person as of the date of this report.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 10, 2020.
- [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.47, inclusive. The Reporting Person undertakes to provide to Dicerna Pharmaceuticals, Inc., any security holder of Dicerna Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
Documents
Issuer
Dicerna Pharmaceuticals Inc
CIK 0001399529
Entity typeother
Related Parties
1- filerCIK 0001598479
Filing Metadata
- Form type
- 4
- Filed
- Sep 20, 8:00 PM ET
- Accepted
- Sep 21, 5:37 PM ET
- Size
- 6.0 KB